XGENERA

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Jul 2025 filing date already counts against anyone who files later.

Record

Serial number

79433300

Mark type

Word mark

Filed

10 Jul 2025

Attorney of record

William C. Wright

Goods and services

• Class 005 — Pharmaceuticals: Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer and pre-cancerous conditions, cardiovascular and cerebrovascular diseases, neurological and neurodegenerative diseases, infectious diseases, inflammatory and autoimmune diseases, metabolic and endocrine diseases, respiratory disease, renal and urological diseases, reproductive related conditions; chemical preparations for testing blood for medical purposes; diagnostic preparations for medical purposes; diagnostic preparations for medical purposes used by medical laboratories; reagents for use in medical testing; diagnostic testing materials for medical use; medical diagnostic test strips for use in the field of oncology, cardiology, neurology, infectious disease, immunology, endocrinology, respiratory medicine, nephrology urology and obstetrics; medical diagnostic reagents; medical testing kits comprised of medical diagnostic reagents and assays for testing body fluids; diagnostic kits comprising diagnostic agents, preparations and substances for medical purposes; chemical preparations for the testing of blood and urine for medical purposes
• Class 010 — Medical apparatus: Medical testing instruments and apparatus, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; apparatus and instruments for use in medical analysis, namely, for detecting and measuring analytes in biofluids; testing probes and testing apparatus for medical diagnostic purposes, namely, medical diagnostic apparatus for testing cancer cells, human blood, urine, tissue, and biofluids; apparatus for DNA and RNA testing for medical purposes; diagnostic instruments for medical use, namely, medical diagnostic apparatus for testing biomarkers; medical test kits primarily comprised of specimen collection tubes and containers for collecting patient specimens and medical diagnostic testing devices for identifying oncological, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, immune system related infection and disease; medical test kits primarily comprised of specimen collection tubes and containers for collecting patient specimens and medical diagnostic testing devices for diagnostic cancer and pre-cancerous conditions, cardiovascular and cerebrovascular diseases, neurological and neurodegenerative diseases, infectious diseases, inflammatory and autoimmune diseases, metabolic and endocrine diseases, respiratory disease, renal and urological diseases, and reproductive related conditions, all for detection purposes; blood and urine testing and analysis apparatus and instruments
• Class 044 — Medical, beauty and agricultural services: Medical testing services; medical analysis services for the diagnosis and treatment of persons; medical testing services relating to the diagnosis and treatment of disease; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing and medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; medical testing services for blood and urine testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories, namely, analysis of human blood, urine, tissue and cells for medical treatment and diagnostics; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories, namely, RNA or DNA analysis services for cancer diagnosis and prognosis; medical laboratory services for the analysis of samples taken from patients relating to the treatment of persons

Owner

• Xgenera Ltd, GB

Prosecution history

• 26 Oct 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 23 Oct 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 23 Oct 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 23 Oct 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 31 Jul 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 31 Jul 2026 — NON-FINAL ACTION E-MAILED
• 31 Jul 2026 — NON-FINAL ACTION WRITTEN
• 08 Jul 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 08 Jul 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 08 Jul 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 29 Jan 2026 — REFUSAL PROCESSED BY IB
• 15 Jan 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
• 15 Jan 2026 — REFUSAL PROCESSED BY MPU
• 06 Dec 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
• 05 Dec 2025 — NON-FINAL ACTION WRITTEN